EKF Diagnostics Holdings plc (AIM: EKF)
London flag London · Delayed Price · Currency is GBP · Price in GBX
25.60
-0.10 (-0.39%)
Nov 19, 2024, 9:26 AM GMT+1

EKF Diagnostics Holdings Company Description

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally.

It offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; Ultracrit, a hematocrit device; DiaSpect Hemoglobin T analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

The company also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic; Quo-Lab A1c, a desktop point-of-care analyzer for measuring glycated hemoglobin; Quo-Test A1c for the monitoring and management of diabetes; and STAT-Site M Beta-hydroxybutyrate analyzer.

In addition, it offers Creamatocrit Plus, a breast milk analyzer; QuPID and True20 pregnancy tests; and Lactate Scout 4, a lactate analyzer.

Further, the company provides clinical chemical analyzers, such as Beta-hydroxybutyrate for monitoring ketosis; Glycated Albumin; Glycated Serum Protein; Nitro-tab Ketone tablets; and Procalcitonin marker for bacterial infection and sepsis, as well as reagents, calibrators, standards, and controls.

Additionally, it offers RaPET Serology immunoassay kits; QuStick Strep A for Strep A infection treatment; Altair 240 and Excel analyzers; Hema-Screen Serology, an analyzer dependent for early detection of colorectal cancer; and kits and other services related to COVID-19, as well as contract manufacturing solutions to third-parties.

The company was founded in 1990 and is headquartered in Cardiff, the United Kingdom.

EKF Diagnostics Holdings plc
Country United Kingdom
Founded 1990
Industry Medical Devices
Sector Healthcare
Employees 317

Contact Details

Address:
Avon House
Cardiff, CF64 2EZ
United Kingdom
Phone 44 29 2071 0570
Website ekfdiagnostics.com

Stock Details

Ticker Symbol EKF
Exchange London Stock Exchange AIM
Fiscal Year January - December
Reporting Currency GBP
ISIN Number GB0031509804
SIC Code 3845